Invention Grant
- Patent Title: Alpha-MSH therapies for treatment of autoimmune disease
- Patent Title (中): α-MSH治疗自身免疫性疾病
-
Application No.: US12897591Application Date: 2010-10-04
-
Publication No.: US08758770B2Publication Date: 2014-06-24
- Inventor: Staley A. Brod
- Applicant: Staley A. Brod
- Applicant Address: US NV Carson City
- Assignee: Research Development Foundation
- Current Assignee: Research Development Foundation
- Current Assignee Address: US NV Carson City
- Agency: Parker Highlander PLLC
- Main IPC: A61K38/22
- IPC: A61K38/22 ; C07K14/575 ; C07K14/47
Abstract:
Methods and compositions for the enteral treatment of autoimmune disease such a multiple sclerosis with polypeptide therapeutics. Enteral therapeutics comprise monomeric alpha-MSH polypeptides such as ACTH. Therapeutic formulations of the invention may be used to reduce the incidence or severity of autoimmune disease. For instance methods for the oral treatment of multiple sclerosis with alpha-MSH and ACTH are described.
Public/Granted literature
- US20110059891A1 ALPHA-MSH THERAPIES FOR TREATMENT OF AUTOIMMUNE DISEASE Public/Granted day:2011-03-10
Information query
IPC分类:
